EU and China pledge dialogue on regulatory policy
This article was originally published in Clinica
The environment is beginning to look increasingly promising for better trade in medical devices and diagnostics between the EU and China.
You may also be interested in...
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.
Butterfly Network is disseminating the lessons from China and Italy about the poential value of lung ultrasound in the management of COVID-19 patients with respiratory disease.